Amundi Asset Management US’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $18.7M | Sell |
109,345
-16,513
| -13% | -$2.83M | 0.01% | 685 |
|
|
2020
Q4 | $27.6M | Sell |
125,858
-168,112
| -57% | -$36.9M | 0.02% | 548 |
|
|
2020
Q3 | $48.8M | Sell |
293,970
-70,629
| -19% | -$11.7M | 0.05% | 334 |
|
|
2020
Q2 | $41.6M | Buy |
364,599
+54,559
| +18% | +$6.23M | 0.05% | 349 |
|
|
2020
Q1 | $23.8M | Buy |
310,040
+75,877
| +32% | +$5.83M | 0.04% | 367 |
|
|
2019
Q4 | $30.2M | Buy |
+234,163
| New | +$30.2M | 0.04% | 439 |
|
|
2019
Q1 | – | Sell |
-268,100
| Closed | -$11.4K | – | 1660 |
|
|
2018
Q4 | $11.4K | Buy |
268,100
+82,900
| +45% | +$3.52K | 0.01% | 620 |
|
|
2018
Q3 | $8.72M | Buy |
+185,200
| New | +$8.72M | 0.01% | 771 |
|